Skip to main content

Day: August 29, 2024

Credicorp Ltd.: Credicorp Announces Special Cash Dividend of S/11.0000 per Share

Lima, Aug. 29, 2024 (GLOBE NEWSWIRE) — LIMA, Peru August 29, 2024 – Credicorp Ltd. (“Credicorp” or the “Company”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia and Panama, announced today that its Board of Directors unanimously agreed to declare a special cash dividend of S/11.0000 per share for a total of S/1,038,205,487.00 in line with the Company´s Bye-Laws. Gianfranco Ferrari, Chief Executive Officer of Credicorp, stated, “This special dividend highlights the strength of our balance sheet and the significant strides in our strategic initiatives. We are advancing on investing in innovation and digital capabilities to meet our clients’ evolving needs while underscoring our commitment to rewarding shareholders.  We remain fully focused on executing our...

Continue reading

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced the publication of its patent application under the international Patent Cooperation Treaty (“PCT”) for innovative combinations of Ketamine and N-Acylethanolamines. The patent application was filed as a result of the Company’s continuous collaboration with SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc”), a specialized pharmaceutical company in the clinical trial phase, dedicated to creating treatments for central nervous system disorders. As part of the collaboration, the two companies are researching combination therapies...

Continue reading

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: CMND) (FSE: CWY), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, Clearmind has announced the publication of its patent application under the international Patent Cooperation Treaty, for innovative combinations of ketamine and N-acylethanolamines. SciSparc and Clearmind, as part of their collaboration, research combination...

Continue reading

Intuitive Machines Strengthens Lunar Service Capabilities with $116.9 million NASA Lunar Contract Award

HOUSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) — NASA has awarded Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, a $116.9 million contract to deliver six science and technology payloads, including one European Space Agency-led drill suite to the Moon’s South Pole. This award will leverage Intuitive Machines’ lunar delivery, data transmission, and autonomous operation capabilities to explore the region targeted for sustained human operations. “Over the last several years, we’ve witnessed NASA’s successful Artemis I mission and the campaign’s progress toward sustainably returning humans to the surface of the Moon, highlighting the importance of autonomous missions that advance humanity’s understanding of the Moon and the commercial services...

Continue reading

Fuel Tech to Present at 26th Annual H.C. Wainwright Global Investment Conference

WARRENVILLE, Ill., Aug. 29, 2024 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced that President & CEO Vince Arnone is scheduled to present at the 26th Annual H.C. Wainwright Global Investment Conference, taking place September 9-11, 2024 in New York City. Presentation Date & Time: September 10, 2024 at 12:00 pm Eastern Time. Live Webcast: Accessible on the Events section of Fuel Tech’s website at www.ftek.com and via the link here. A replay will be available for up to 90 days following the event. Mr. Arnone will also host one-on-one meetings with investors at the conference. To request a one-on-one meeting, please contact your H.C. Wainwright...

Continue reading

Great Elm Group Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results

Company to Host Conference Call at 8:30 a.m. ET on August 30, 2024 PALM BEACH GARDENS, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) — Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2024.  Fiscal Fourth Quarter 2024 and Recent HighlightsGreat Elm Capital Corp. (“GECC”) raised $34 million of additional debt and equity capital since April 2024. Fee-paying assets under management (“FPAUM”) and assets under management (“AUM”) both increased 6% in the quarter. Pro forma FPAUM1 and AUM1, inclusive of net proceeds from GECC’s July capital raise, totaled approximately $546 million and $749 million, respectively.Represents pro forma FPAUM1 and AUM1 growth of 11% and 9%, respectively,...

Continue reading

Rail Vision Announces First Half 2024 Financial Results

RA’ANANA, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), a development stage technology company seeking to revolutionize railway safety and the data-related market, today reported financial results for the first half ended June 30, 2024. “We continued to strengthen our foundation during 2024, completing a series of financing transactions that raised gross proceeds of over $12 million. On a business level, securing orders from global leaders and successfully delivering our advanced systems have been important milestones for us. I’m proud to say that all installations have been carried out with industry-leading partners, further strengthening our presence in the U.S. market. The positive feedback we’re receiving from these esteemed customers aligns with our commitment to...

Continue reading

Kane Biotech Announces Second Quarter 2024 Financial Results

Company Realizes $10.4M Gain on the Sale of STEM WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second quarter 2024 financial results. The second quarter 2024 financial results reflect the closing of the sale of STEM which took place on April 12, 2024. The Company recorded a gain of $10,359,882 on this transaction which is offset by income tax loss carry forwards for income tax purposes. Second Quarter 2024 Financial Highlights (Including Discontinued STEM Operations):License and royalty income for the three months ended June 30, 2024 was $299,992, an increase of 74% compared to $172,877 in the three months ended June 30, 2023. The increase is due mainly to the Company recognizing as license revenue the outstanding...

Continue reading

ARMOUR Residential REIT, Inc. Announces September 2024 Dividend Rate Per Common Share

VERO BEACH, Florida, Aug. 29, 2024 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced the September 2024 cash dividend for the Company’s Common Stock. September 2024 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateSeptember 2024   $0.24   September 16, 2024   September 27, 2024             Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined...

Continue reading

NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization

EINDHOVEN, The Netherlands, Aug. 29, 2024 (GLOBE NEWSWIRE) — As part of its ongoing capital return program, NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that its board of directors has approved the payment of an interim dividend and additional share repurchase authorization. The actions are based on the continued and significant strength of the NXP capital structure, and the board’s confidence in the company’s ability to drive long-term growth and strong cash flow. The board of directors has approved the payment of an interim dividend of $1.014 per ordinary share for the third quarter of 2024. The interim dividend will be paid in cash on October 9, 2024, to shareholders of record as of September 12, 2024. Additionally, consistent with NXP’s historic policy of returning excess cash flow to shareholders, the board of directors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.